LYEL
Lyell Immunopharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$11.01
+1.94%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.15x
- Price / sales
- 9992.65x
- Price / cash flow
- -2.02x
Enterprise value
- Enterprise value
- $102.6M
- EV / sales
- 3801.24x
- EV / EBITDA
- -0.43x
- EV / EBIT
- -0.53x
- Market cap
- $269.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026